Upcoming Events

Dexter Pratt (UCSD) will explore issues in developing AI agents that evaluate the behavior of other agents. Agent-based judges will almost certainly have problems with bias and consistency, but can we create judges that are good enough to be useful? Click here to learn more information.

The Medical Imaging and Data Resource Center (MIDRC) will be hosting an upcoming seminar on Tuesday, June 18. The talk, "Introducing MIDRC Helper AI: A Demonstration of Enhanced Medical Imaging Analysis," will be held virtually at 3PM ET. Held on the third Tuesday of the month, the MIDRC seminar series is an opportunity for members of the medical community at large to hear directly from the MIDRC Team! This session will feature research presentations from MIDRC investigators on new and noteworthy advances, and includes a live Q&A session for all attendees. The speakers for this session will be Maryam Vazirabad, M.S., from RSNA; George Shih, M.D., from Weill Cornell Medical College; and Adam Flanders, M.D., from Thomas Jefferson University. These virtual seminars are free and open to everyone. We hope you'll join us throughout the year for these engaging discussions. Seminar registration is required to attend. For more information on the seminar series, visit the MIDRC website.

Please join us on Tuesday, June 18th at 12pm-1pm PST/3pm-4pm EST for the lecture “Regulatory Considerations: Health Equity, AI, and Bias ” by Dr. Michael D. Abramoff, MD, PhD Zoom link: https://washington.zoom.us/j/93878229164 Michael D. Abramoff, MD, PhD, is a fellowship-trained retina specialist, computer scientist and entrepreneur. Dr. Michael Abramoff, MD, PhD, (Gold Fellow, ARVO and Fellow, IEEE) is the Robert C. Watzke, Professor of Ophthalmology and Visual Sciences at the University of Iowa, with a joint appointment in the College of Engineering. Dr. Abramoff is also Founder and Executive Chairman of Digital Diagnostics, the Autonomous AI diagnostics company that was the first in any field of medicine to get FDA clearance for an autonomous AI, where the AI makes a medical decision without human oversight, and which, in primary care, it can instantaneously diagnose diabetic retinopathy and diabetic macular edema at the point of care. Dr. Abramoff developed an ethical foundation for autonomous AI that was used during the design, validation, of AI and regulatory and reimbursement pathways for autonomous AI. The results of randomized controlled trials show that it increases clinician productivity, lowers cost, and improves health equity, patient outcomes, and care access. Finally, he is founder of the Healthcare AI coalition, representing many healthcare AI companies, and a founding member and treasurer of FDA’s Collaborative Community on Ophthalmic Imaging. As the author of over 400 peer-reviewed publications in this field, he has been cited over 47,000 times (h-index 80), and is the inventor on 25 issued patents and many patent applications. Dr. Abramoff has mentored dozens of engineering graduate students, ophthalmology residents, and retina fellows. His passion is to use autonomous AI to improve the productivity and accessibility of healthcare. Link to previous lecture recordings and terms of the month: https://aireadi.org/blog